Page last updated: 2024-10-31

metoprolol and Jejunal Diseases

metoprolol has been researched along with Jejunal Diseases in 2 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Jejunal Diseases: Pathological development in the JEJUNUM region of the SMALL INTESTINE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avdeef, A1
Tam, KY1
Nellgård, P1
Bojö, L1
Jönsson, A1
Cassuto, J1

Other Studies

2 other studies available for metoprolol and Jejunal Diseases

ArticleYear
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
    Journal of medicinal chemistry, 2010, May-13, Volume: 53, Issue:9

    Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological

2010
Influence of adrenoceptor agonists and antagonists on fluid secretion in small bowel obstruction.
    European journal of gastroenterology & hepatology, 1995, Volume: 7, Issue:11

    Topics: Adrenergic Agonists; Adrenergic Antagonists; Albuterol; Analysis of Variance; Animals; Body Water; C

1995